Zimmer Biomet Holdings, Inc (NYSE:ZBH) announced plans to phase out its CPT Hip System by December. The decision comes on the heels of a warning from the U.S. Food and Drug Administration (FDA), ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Zimmer Biomet issued a field safety corrective notice ...
This week, FDA issued a safety communication connected to Zimmer Biomet’s CPT Hip System Femoral Stem after finding increased risk of thigh bone fracture — postoperative periprosthetic femoral ...
(RTTNews) - The U.S. Food and Drug Administration has issued a safety alert about the increased risk of thigh bone fracture after surgery with the use of the Zimmer Biomet CPT Hip System, which was ...
On Wednesday, Zimmer Biomet Holdings, Inc (NYSE:ZBH) reported third-quarter adjusted EPS of $1.74, up from $1.65 a year ago, in line with the Street estimates. The orthopedic giant reported sales of ...
WARSAW, Ind., Oct. 28, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (ZBH), a global medical technology leader, today announced the U.S. Food and Drug Administration (FDA) has granted Breakthrough ...
Zimmer Biomet Holdings, Inc. ZBH recently announced the signing of a definitive agreement to acquire OrthoGrid Systems, Inc., a privately-held medical technology company focused on artificial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results